OBRATORI, L'Occitane Group Ventures
Corporate venture capital arm of L'Occitane Group, the Manosque-based premium natural beauty group behind L'Occitane en Provence, Melvita, Erborian and, since 2021, Sol de Janeiro. Founded in 2019 in Marseille, it makes early-stage seed and Series A investments across sustainable beauty, biotech, clean cosmetics, e-health, wellbeing, plant-based actives, foodtech and retailtech under its 'Better for people and for the planet' criterion. The portfolio counts 15 active companies as of 2026, out of 22 cumulative investments, with no confirmed exits to date; the 2019-vintage program remains in active deployment.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 24 portfolio companies (24 active · 0 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
24 companiesFunds & portfolio
Every fund OBRATORI, L'Occitane Group Ventures has raised, with its portfolio companies. Hand-checked from public filings.
ObratoriVC2019 · 7yr€30M24 active
Unrealized
24 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| – | – | 2019 | |
| – | – | 2019 | |
| Biotech | 2021 | ||
| ClimateTech | 2023 | ||
| – | – | 2019 | |
| – | – | 2019 | |
| ClimateTech | 2022 | ||
| SaaS | 2022 | ||
| HealthTech | 2018 | ||
| – | – | 2019 | |
| Consumer | 2024 | ||
| Consumer | 2022 | ||
| Fintech | 2023 | ||
| Consumer | 2024 | ||
| Consumer | 2019 | ||
| – | – | 2019 | |
| Consumer | 2021 | ||
| – | – | 2019 | |
| – | – | 2019 | |
| – | – | 2019 | |
| Consumer | 2021 | ||
| HealthTech | 2022 | ||
| Consumer | 2021 | ||
| SaaS | 2023 |
Saved GPs appear in your watchlist, one click from your workspace.
About OBRATORI, L'Occitane Group Ventures
OBRATORI, L'Occitane Group Ventures is a venture capital platform based in Paris with capital deployed across 2 active fund vehicles. The firm targets European and selectively global technology companies across consumer, healthcare and business services, with capital deployed across early-stage and Series A/B rounds alongside institutional limited partners.
Investment thesis
The platform deploys venture capital into consumer, healthcare and business services categories with a focus on technology-enabled businesses across France and selectively across Europe. Investment focus spans seed and growth stages with capital deployed across multiple rounds per portfolio company, supporting founder teams through international scaling and selective M&A activity. The fund structure enables longer holding periods than typical venture vehicles, supporting category-leadership outcomes in technology platforms with global ambitions.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 2 fund vehicles, 16 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on OBRATORI, L'Occitane Group Ventures.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in